The Effect of Injection Site Cooling on Pain Experienced After the Administration of CNTX-4975-05 Into the Knee

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 21, 2018

Primary Completion Date

July 27, 2018

Study Completion Date

August 3, 2018

Conditions
Osteoarthritis, Knee
Interventions
OTHER

Ice Pack and Cooling Device

A comparison of two cooling methodologies in healthy volunteers after single intra-articular (IA) injection (15 mL) of 2% lidocaine (without epinephrine).

DRUG

CNTX-4975-05 (trans-capsaicin)

Controlled cooling wrap vs ice pack cooling after single IA injection of 1 mg CNTX-4975-05 in each arm after single IA (15 mL) injection of 2% lidocaine (without epinephrine).

DRUG

CNTX-4975-05 (trans-capsaicin)

Controlled cooling parameters will be determined after evaluation of data from prior Cohort(s) after single IA injection (15 mL) of 2% lidocaine (without epinephrine) and single IA injection of 1 mg CNTX-4975-05.

DRUG

CNTX-4975-05 (trans-capsaicin)

Controlled cooling with knee device vs no cooling (determined after evaluation of data from previous cohorts) after single IA injection (15 mL) of 2% lidocaine (without epinephrine) and single IA injection of 1 mg CNTX-4975-05.

DRUG

Capsaicin

Four intradermal injections of capsaicin, two on each forearm.

Trial Locations (1)

Unknown

MAC Clinical Research, Manchester

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY